You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Smolen JS, Cohen SB, Tony H, et al
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases 2017;76:1598-1602.